# A Multicenter "Ablate and Resect" Study of Novilase® Interstitial Laser Therapy for the Ablation of Small Breast Cancers

> **NCT01478438** · NA · UNKNOWN · sponsor: **Novian Health Inc.** · enrollment: 60 (estimated)

## Conditions studied

- Malignant Tumor

## Interventions

- **DEVICE:** Novilase Interstitial Laser Therapy

## Key facts

- **NCT ID:** NCT01478438
- **Lead sponsor:** Novian Health Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2012-04
- **Primary completion:** 2015-12
- **Final completion:** 2021-08
- **Target enrollment:** 60 (ESTIMATED)
- **Last updated:** 2021-03-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01478438

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01478438, "A Multicenter "Ablate and Resect" Study of Novilase® Interstitial Laser Therapy for the Ablation of Small Breast Cancers". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01478438. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*